Prognostic outcome of cervical laser ablation using a holmium yttrium-aluminum-garnet (Ho:YAG) laser for the treatment of cervical intraepithelial neoplasia: A single-center retrospective study

• Published in: Gynecologic oncology reports 2024-06, Vol.53, p.101405-101405, Article 101405
• Main Authors: Suzuki, Wataru, Ietani, Kana, Makabe, Takeshi, Oki, Shinya, Ohno, Akiko, Mikami, Yoshiko, Yamashita, Hiroshi
• Format: Article
• Language: English
• Subjects: Human Papillomavirus Viruses; Lasers, Solid-State; Research Report; Uterine Cervical Dysplasia
• ISSN: 2352-5789; 2352-5789
• DOI: 10.1016/j.gore.2024.101405

•The Ho:YAG laser is used in laser ablation, but there are no reports on its effectiveness.•Laser ablation with the Ho:YAG laser is highly effective.•High-risk HPV test after laser ablation needs to be routinely performed. Although cervical conization is considered a standard treatment for cervical intraepithelial neoplasia (CIN) 2/3, laser ablation can compensate for the disadvantages of the former. CO2, semiconductor, and holmium yttrium-aluminum-garnet (Ho:YAG) lasers are applied in ablation, but no previous studies have shown the effectiveness of any of these techniques. Here, we retrospectively analyzed the application of the Ho:YAG laser in our hospital to verify its efficacy, and discussed the methods for optimal recurrence detection. We evaluated the recurrence rates of the pathological condition in patients who underwent laser ablation with a Ho:YAG laser for CIN2/3 at our institution from June 2012 to November 2021. We defined the recurrence as histologically confirmed CIN2 or more advanced stage. Age, preoperative diagnosis, human papillomavirus (HPV) genotype, and postoperative high-risk HPV status were recorded to establish their association with recurrence rates. We performed surgery in 607 patients and the 2-year recurrence rate after interventions was 5.6%. Five patients were diagnosed with invasive cancer at the time of recurrence. Older age significantly correlated with higher risk of recurrence, but preoperative CIN grade and preoperative HPV 16/18 status did not significantly affect it. The postoperative high-risk HPV test was 100% sensitive for detecting recurrence. Laser ablation with the Ho:YAG laser yields promising results. Together with postinterventional management, high-risk HPV test after laser ablation should be conducted after diagnostic conization. This study received the approval from the Ethics Committee of the NHO Tokyo Medical Center (Ethics Committee approval number: R22-067).